Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Role of pancreatic cancer-derived exosomes in salivary biomarker development.

Lau C, Kim Y, Chia D, Spielmann N, Eibl G, Elashoff D, Wei F, Lin YL, Moro A, Grogan T, Chiang S, Feinstein E, Schafer C, Farrell J, Wong DT.

J Biol Chem. 2013 Sep 13;288(37):26888-97. doi: 10.1074/jbc.M113.452458. Epub 2013 Jul 23.

2.

Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer.

Gao K, Zhou H, Zhang L, Lee JW, Zhou Q, Hu S, Wolinsky LE, Farrell J, Eibl G, Wong DT.

PLoS One. 2009 Jun 11;4(6):e5875. doi: 10.1371/journal.pone.0005875.

3.

Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM).

Tu M, Wei F, Yang J, Wong D.

J Vis Exp. 2015 Jan 23;(95):52439. doi: 10.3791/52439.

PMID:
25650727
4.
5.

Detection of tumor cell-specific mRNA and protein in exosome-like microvesicles from blood and saliva.

Yang J, Wei F, Schafer C, Wong DT.

PLoS One. 2014 Nov 14;9(11):e110641. doi: 10.1371/journal.pone.0110641. eCollection 2014.

6.

Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.

Madhavan B, Yue S, Galli U, Rana S, Gross W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, Zöller M.

Int J Cancer. 2015 Jun 1;136(11):2616-27. doi: 10.1002/ijc.29324. Epub 2014 Nov 25.

7.

Salivary MicroRNA in Pancreatic Cancer Patients.

Humeau M, Vignolle-Vidoni A, Sicard F, Martins F, Bournet B, Buscail L, Torrisani J, Cordelier P.

PLoS One. 2015 Jun 29;10(6):e0130996. doi: 10.1371/journal.pone.0130996. eCollection 2015.

8.

Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.

Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong DT.

Gastroenterology. 2010 Mar;138(3):949-57.e1-7. doi: 10.1053/j.gastro.2009.11.010. Epub 2009 Nov 18.

9.

Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer.

Xie Z, Yin X, Gong B, Nie W, Wu B, Zhang X, Huang J, Zhang P, Zhou Z, Li Z.

Cancer Prev Res (Phila). 2015 Feb;8(2):165-73. doi: 10.1158/1940-6207.CAPR-14-0192. Epub 2014 Dec 23.

10.

Development of transcriptomic biomarker signature in human saliva to detect lung cancer.

Zhang L, Xiao H, Zhou H, Santiago S, Lee JM, Garon EB, Yang J, Brinkmann O, Yan X, Akin D, Chia D, Elashoff D, Park NH, Wong DT.

Cell Mol Life Sci. 2012 Oct;69(19):3341-50. doi: 10.1007/s00018-012-1027-0. Epub 2012 Jun 12.

11.

Characterization and proteomic analysis of ovarian cancer-derived exosomes.

Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K.

J Proteomics. 2013 Mar 27;80:171-82. doi: 10.1016/j.jprot.2012.12.029. Epub 2013 Jan 16.

PMID:
23333927
12.

Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.

Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, Akin D, Yan X, Chia D, Karlan B, Wong DT.

PLoS One. 2010 Dec 31;5(12):e15573. doi: 10.1371/journal.pone.0015573.

13.

Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma.

Lee YH, Kim JH, Zhou H, Kim BW, Wong DT.

J Mol Med (Berl). 2012 Apr;90(4):427-34. doi: 10.1007/s00109-011-0829-0. Epub 2011 Nov 18.

PMID:
22095100
14.

The potential of tumor-derived exosomes for noninvasive cancer monitoring.

Whiteside TL.

Expert Rev Mol Diagn. 2015;15(10):1293-310. doi: 10.1586/14737159.2015.1071666. Epub 2015 Aug 2. Review.

15.
16.

Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing.

Ogawa Y, Taketomi Y, Murakami M, Tsujimoto M, Yanoshita R.

Biol Pharm Bull. 2013;36(1):66-75.

17.

Salivary transcriptome diagnostics for oral cancer detection.

Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT.

Clin Cancer Res. 2004 Dec 15;10(24):8442-50.

18.

Intercepting Cancer Communiques: Exosomes as Heralds of Malignancy.

Hingorani SR.

Cancer Cell. 2015 Aug 10;28(2):151-3. doi: 10.1016/j.ccell.2015.07.015.

19.

Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.

Wang H, Rana S, Giese N, Büchler MW, Zöller M.

Int J Cancer. 2013 Jul 15;133(2):416-26. doi: 10.1002/ijc.28044. Epub 2013 Feb 15.

20.

Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery.

Principe S, Hui AB, Bruce J, Sinha A, Liu FF, Kislinger T.

Proteomics. 2013 May;13(10-11):1608-23. doi: 10.1002/pmic.201200533. Review.

PMID:
23505015
Items per page

Supplemental Content

Write to the Help Desk